Our study provides the first transcriptomic evidence linking GAstV-induced renal injury to bile acid metabolic disruption, with AGXT—a key enzyme in glyoxylate detoxification—emerging as a central mediator of hyperuricemia and gout pathogenesis. The gene discussed is AGXT; the disease is hyperuricemia.